These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20649817)

  • 1. Metabolic changes of anterior cingulate cortex in patients with hepatic cirrhosis: A magnetic resonance spectroscopy study.
    Zhang LJ; Lu GM; Yin JZ; Qi J
    Hepatol Res; 2010 Aug; 40(8):777-85. PubMed ID: 20649817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disrupted metabolic and functional connectivity patterns of the posterior cingulate cortex in cirrhotic patients: a study combining magnetic resonance spectroscopy and resting-state functional magnetic resonance imaging.
    Lu L; Wang J; Zhang L; Zhang Z; Ni L; Qi R; Kong X; Lu M; Sami MU; Xu K; Lu G
    Neuroreport; 2018 Aug; 29(12):993-1000. PubMed ID: 29952814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of subclinical and overt hepatic encephalopathy and treatment control after L-ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H-MRS)].
    Hass HG; Nägele T; Seeger U; Hösl F; Gregor M; Kaiser S
    Z Gastroenterol; 2005 Apr; 43(4):373-8. PubMed ID: 15830303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis.
    Ahluwalia V; Wade JB; Thacker L; Kraft KA; Sterling RK; Stravitz RT; Fuchs M; Bouneva I; Puri P; Luketic V; Sanyal AJ; Gilles H; Heuman DM; Bajaj JS
    J Hepatol; 2013 Sep; 59(3):467-73. PubMed ID: 23665182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disrupted functional connectivity of the anterior cingulate cortex in cirrhotic patients without overt hepatic encephalopathy: a resting state fMRI study.
    Zhang LJ; Qi R; Zhong J; Ni L; Zheng G; Xu J; Lu GM
    PLoS One; 2013; 8(1):e53206. PubMed ID: 23308163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viability assessment of magnetic resonance spectroscopy for the detection of minimal hepatic encephalopathy severity.
    Meng LP; Chen YC; Li YH; Zhu JS; Ye JL
    Eur J Radiol; 2015 Oct; 84(10):2019-23. PubMed ID: 26170124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of functional magnetic resonance imaging of the brain in the evaluation of hepatic encephalopathy in cirrhotic patients.
    Abdelhamid MAM; Abdelsameea E; Korayem EM; Alwarraky MS; Omar HM
    Clin Exp Hepatol; 2022 Dec; 8(4):321-329. PubMed ID: 36683873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of cognitivity, proinflammatory cytokines, and brain magnetic resonance imaging in minimal hepatic encephalopathy induced by cirrhosis and extrahepatic portal vein obstruction.
    Yadav SK; Goel A; Saraswat VA; Thomas MA; Wang E; Marincola FM; Haris M; Gupta RK
    J Gastroenterol Hepatol; 2016 Dec; 31(12):1986-1994. PubMed ID: 27119420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton magnetic resonance spectroscopy (1H-MRS) findings for the brain in patients with liver cirrhosis reflect the hepatic functional reserve.
    Lee JH; Seo DW; Lee YS; Kim ST; Mun CW; Lim TH; Min YI; Suh DJ
    Am J Gastroenterol; 1999 Aug; 94(8):2206-13. PubMed ID: 10445551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic alterations in the right anterior insula among patients with cirrhosis without overt hepatic encephalopathy: a magnetic resonance spectroscopy study.
    Huang NX; Huang HW; Dong QY; Wen YL; Li D; Li JQ; Chen HJ
    Front Neurol; 2023; 14():1291478. PubMed ID: 38283679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can Lactobacillus acidophilus improve minimal hepatic encephalopathy? A neurometabolite study using magnetic resonance spectroscopy.
    Ziada DH; Soliman HH; El Yamany SA; Hamisa MF; Hasan AM
    Arab J Gastroenterol; 2013 Sep; 14(3):116-22. PubMed ID: 24206740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral 1H MR spectroscopy and neuropsychologic status of patients with hepatic encephalopathy.
    Thomas MA; Huda A; Guze B; Curran J; Bugbee M; Fairbanks L; Ke Y; Oshiro T; Martin P; Fawzy F
    AJR Am J Roentgenol; 1998 Oct; 171(4):1123-30. PubMed ID: 9763008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal hepatic encephalopathy in patients with liver cirrhosis: magnetic resonance spectroscopic brain findings versus neuropsychological changes.
    Hassan EA; Abd El-Rehim AS; Seifeldein GS; Shehata GA
    Arab J Gastroenterol; 2014; 15(3-4):108-13. PubMed ID: 25459346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal hepatic encephalopathy in children: evaluation with proton MR spectroscopy.
    Foerster BR; Conklin LS; Petrou M; Barker PB; Schwarz KB
    AJNR Am J Neuroradiol; 2009 Sep; 30(8):1610-3. PubMed ID: 19509075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of
    Boruah DK; Marak R; Bhuyan D; Mazumdar H; Patgiri SJ
    J Neurosci Rural Pract; 2024; 15(2):245-254. PubMed ID: 38746531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-dimensional MR spectroscopy of minimal hepatic encephalopathy and neuropsychological correlates in vivo.
    Singhal A; Nagarajan R; Hinkin CH; Kumar R; Sayre J; Elderkin-Thompson V; Huda A; Gupta RK; Han SH; Thomas MA
    J Magn Reson Imaging; 2010 Jul; 32(1):35-43. PubMed ID: 20578008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Relationship Between Brain Metabolites Alterations and Neuropsychological Deficits in Patients with Methamphetamine Use Disorder: A Proton Magnetic Resonance Spectroscopy Study.
    Bakhshinezhad H; Darharaj M; Feyzi YF; Babaei S; Ahadi R; Jamei B; Pourhamzeh M; Daneshi A; Arezoomandan R
    Arch Clin Neuropsychol; 2022 Jan; 37(1):160-172. PubMed ID: 33993207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mania, glutamate/glutamine and risperidone in pediatric bipolar disorder: a proton magnetic resonance spectroscopy study of the anterior cingulate cortex.
    Moore CM; Biederman J; Wozniak J; Mick E; Aleardi M; Wardrop M; Dougherty M; Harpold T; Hammerness P; Randall E; Lyoo IK; Renshaw PF
    J Affect Disord; 2007 Apr; 99(1-3):19-25. PubMed ID: 17005256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR imaging and (1)H spectroscopy of brain metabolites in hepatic encephalopathy: time-course of renormalization after liver transplantation.
    Naegele T; Grodd W; Viebahn R; Seeger U; Klose U; Seitz D; Kaiser S; Mader I; Mayer J; Lauchart W; Gregor M; Voigt K
    Radiology; 2000 Sep; 216(3):683-91. PubMed ID: 10966695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR imaging and spectroscopy of the basal ganglia in chronic liver disease: correlation of T1-weighted contrast measurements with abnormalities in proton and phosphorus-31 MR spectra.
    Taylor-Robinson SD; Sargentoni J; Oatridge A; Bryant DJ; Hajnal JV; Marcus CD; Seery JP; Hodgson HJ; deSouza NM
    Metab Brain Dis; 1996 Sep; 11(3):249-68. PubMed ID: 8869945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.